Any stock, in context
PANACEABIO · Healthcare
Panacea Biotec Limited
Observation · 15 Oct 2026
How these are readPanacea Biotec closed at ₹357.0 on 15 Oct 2026, 11.3% below its 200-day average and 7.4% below its 50-day average: below both lines. It sits 41.3% below its highest close of the past year, in the bottom fifth of its one-year range. Over three months it fell 35.0%, against a median of −2.7% for its sector (146 stocks) and −5.1% for every stock observed.
- vs 200-day
- −11.3%
- the long line
- vs 50-day
- −7.4%
- the short line
- From 52w high
- −41.3%
- ₹292.4₹647.0
- 3 months
- −35.0%
- sector median −2.7% · 144 of 146
Listed outside the Nifty indices · Healthcare (sector mapped from its industry) · EQ series · median traded value ₹3.93 crore a day. A description of where the price sits, not a view on the stock.
- 1D
- −0.97%
- 1W
- –
- 1M
- −4.99%
- 3M
- −34.95%
- YTD
- –
- 1Y
- −21.02%
Quotes come from Yahoo Finance through this site's server and are cached for fifteen minutes; when the provider fails, the stored close is shown and labelled. The observation is computed from the latest snapshot. For research and education only; not investment advice.